Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Biosensing Platform Detects Bacterial Pneumonia

By LabMedica International staff writers
Posted on 05 Jan 2011
A technique has been developed that will diagnose and differentiate the organisms that cause pneumonia using nanotechnology.

The method combined the existing technology of surface-enhanced Raman spectroscopy (SERS) with silver nanorods to identify different strains of Mycoplasma pneumoniae. More...
Raman spectroscopy works by detecting spectral signatures of a near-infrared laser as it scatters off a biological specimen.

Scientists at the University of Georgia (UGA; Athens, GA, USA), were able to detect and differentiate M. pneumoniae strains from throat swabs. They equated the nanorod array system to a brush with densely packed bristles, where each of the tiny silver rods extends out at a specific angle. The sample, such as bacteria from a throat swab, penetrates among the bristles, where the spectral signature produced by the laser is amplified and then analyzed by a computer program.

Clinical throat swab samples, collected from the University of Alabama (Birmingham, AL, USA), were processed by extraction and subsequently tested by polymerase chain reaction (PCR). Three M. pneumoniae strains were reproducibly differentiated by nanorod-SERS (NA-SERS), with 95%–100% specificity and 94%–100% sensitivity, and with a lower detection limit exceeding standard PCR. In addition, NA-SERS correctly classified with greater than 97% accuracy, 10 true clinical throat swab samples previously established by real-time PCR and culture to be positive or negative for M. pneumoniae.

Duncan C. Krause, PhD, a professor of microbiology at UGA, said, "If you can make a positive identification from a 10-minute test, then appropriate antibiotics can be prescribed, limiting both the consequences in that patient and the likelihood that it will spread to others. The device can be reduced to a size that could fit in a briefcase, although testing is currently done only in a laboratory setting. Our hope is that when we begin to explore the capabilities of this technology, it can be applied in point-of-care testing. Then the impact becomes truly significant."

Infections due to M. pneumoniae are very common yet difficult to diagnose. The bacterium is a major cause of respiratory disease in humans accounting for 20% of all community-acquired pneumonia and the leading cause of pneumonia in older children and young adults. It can cause permanent damage to the lungs if not diagnosed promptly. A delay in diagnosis extends the likelihood for complications as well as continued transmission to the community. The study was published online December 2010 in PLoS One.

Related Links:

University of Georgia
University of Alabama



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.